Literature DB >> 16965387

Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major.

Athanasios Christoforidis, Vassilios Perifanis, Miranda Athanassiou-Metaxa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965387     DOI: 10.1111/j.1365-2141.2006.06296.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 2.  A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.

Authors:  Shayma Ahmed; Ashraf Soliman; Vincenzo De Sanctis; Nada Alaaraj; Fawzia Alyafei; Noor Hamed; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-08-31

3.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

4.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

Review 5.  The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Eur J Haematol       Date:  2007-12-10       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.